Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2026
Generative Artificial Intelligence (AI) In Drug Discovery Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2026

Global Outlook – By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

• Generative Artificial Intelligence (AI) In Drug Discovery market size has reached to $0.25 billion in 2025

• Expected to grow to $0.86 billion in 2030 at a compound annual growth rate (CAGR) of 27%

• Growth Driver: Rising Clinical Trials on the Generative AI in Drug Discovery Market

• Market Trend: Advanced AI Solutions To Revolutionize Drug Discovery And Precision Medicine

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Generative Artificial Intelligence (AI) In Drug Discovery Market?

Generative AI in drug discovery involves using advanced machine learning, especially generative models, to create and identify new pharmaceutical compounds. These AI systems analyze extensive data, including chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary aim of generative AI in drug discovery is to accelerate the creation and identification of novel pharmaceutical compounds with potential therapeutic effects, optimizing the drug development process by leveraging extensive data to predict and generate new molecules efficiently.

The main types of generative artificial intelligence (AI) in drug discovery are small molecule and large molecule. The small molecules are drugs that are chemically synthesized and typically have a low molecular weight. The technologies include deep learning, machine learning, reinforcement learning, molecular docking, and quantum computing are used by various end-users including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and others.

Generative Artificial Intelligence (AI) In Drug Discovery Market Global Report 2026 Market Report bar graph

What Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Size and Share 2026?

The generative artificial intelligence (ai) in drug discovery market size has grown exponentially in recent years. It will grow from $0.25 billion in 2025 to $0.33 billion in 2026 at a compound annual growth rate (CAGR) of 30.6%. The growth in the historic period can be attributed to high drug development costs, growth in computational chemistry, availability of biological datasets, adoption of machine learning tools, pharmaceutical r&d investment.

What Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Growth Forecast?

The generative artificial intelligence (ai) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $0.86 billion in 2030 at a compound annual growth rate (CAGR) of 27.0%. The growth in the forecast period can be attributed to integration of generative models in pipelines, demand for faster drug discovery, expansion of biologics optimization, collaboration between ai firms and pharma, reduced time-to-market. Major trends in the forecast period include rising adoption of AI-driven molecule generation, increased use of deep learning in drug design, expansion of small molecule discovery applications, growing integration of ai in lead optimization, accelerated early-stage drug development.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Generative Artificial Intelligence (AI) In Drug Discovery Market Segmentation

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

What Is The Driver Of The Generative Artificial Intelligence (AI) In Drug Discovery Market?

The rising number of clinical trials is expected to propel the growth of generative AI in the drug discovery market. Clinical trials involve human volunteers and assess the safety and effectiveness of new medical treatments or procedures, aiming to gather scientific data on their suitability for human use. The rising number of clinical trials is primarily attributed to advancements in medical research, increased disease burden, regulatory changes, globalization of clinical research, patient advocacy and awareness, industry competition, technological advancements, and funding opportunities. Clinical trial data fuels generative AI models, expediting drug discovery by predicting interactions and designing compounds. This synergy enables personalized medicine, optimizes treatment efficacy, improves patient outcomes, and revolutionizes the pharmaceutical landscape. For instance, in January 2025, according to Pharmaceutical Technology, a UK-based business news and media company, there are 3,213 trials planned to start this year, including 823 in Phase I and 1,102 in Phase II. As with 2024, oncology is expected to remain the top therapeutic area, accounting for 946 trials, followed by the central nervous system with 686 trials, then cardiovascular some way behind with 258 trials. Therefore, the rising number of clinical trials is driving the growth of generative AI in the drug discovery market.

Key Players In The Global Generative Artificial Intelligence (AI) In Drug Discovery Market

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

Global Generative Artificial Intelligence (AI) In Drug Discovery Market Trends and Insights

Major companies operating in the generative AI in the drug discovery market are developing advanced AI-powered tools to accelerate drug discovery processes. AI-powered tools accelerate drug development by streamlining drug discovery, design, and clinical trials through predictive analytics and machine learning. They enhance efficiency in target identification and compound screening such as virtual screening using AI, preclinical development, regulatory compliance, and manufacturing processes. For instance, in May 2023, Google Cloud, a US-based cloud computing service provided by Google, introduced two innovative AI-driven solutions. These solutions, the Target and Lead Identification Suite and the Multiomics Suite are designed to improve drug discovery and precision medicine across biotech, pharmaceutical, and public sector organizations. The Target and Lead Identification Suite helps researchers understand amino acid functions and predict protein structures, while the Multiomics Suite speeds up the analysis and understanding of genomic data, simplifying the development of personalized treatments.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market?

In May 2023, Recursion Pharmaceuticals, a US-based clinical-stage TechBio company, acquired Cyclica and Valence for $40 million and $47.5 million. The acquisitions of Cyclica and Valence by Recursion have significantly enhanced its drug discovery capabilities through advanced technologies. This positions Recursion as a leading hub for top-tier professionals in ML and AI, poised to innovate and drive the future of drug discovery. Cyclica Inc. is a Canada-based biotechnology company specializing in data-driven drug discovery, biophysics, and artificial intelligence to develop predictive analytics software, and Valence Labs is a Canada-based AI-driven research organization that focuses on advancing the frontier of AI in drug discovery.

Regional Outlook

North America was the largest region in the generative AI in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generative Artificial Intelligence (AI) In Drug Discovery Market?

The generative AI in drug discovery market includes revenues earned by entities by providing services such as molecule generation, optimization, virtual screening, predictive modeling, de novo drug design, and consulting support. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative AI in drug discovery market also includes sales of quantum computers, high-performance computing (HPC) clusters, tensor processing units, graphics processing units, and preclinical development tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2026?

The generative artificial intelligence (ai) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (ai) in drug discovery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Generative Artificial Intelligence (AI) In Drug Discovery Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.33 billion
Revenue Forecast In 2035 $0.86 billion
Growth Rate CAGR of 30.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Technology, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Generative Artificial Intelligence (AI) In Drug Discovery Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Generative Artificial Intelligence (AI) In Drug Discovery Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of AI-Driven Molecule Generation

4.2.2 Increased Use Of Deep Learning In Drug Design

4.2.3 Expansion Of Small Molecule Discovery Applications

4.2.4 Growing Integration Of AI In Lead Optimization

4.2.5 Accelerated Early-Stage Drug Development

5. Generative Artificial Intelligence (AI) In Drug Discovery Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Contract Research Organizations

5.4 Academic Research Institutes

5.5 Drug Discovery Startups

6. Generative Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Generative Artificial Intelligence (AI) In Drug Discovery Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Generative Artificial Intelligence (AI) In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Size, Comparisons And Growth Rate Analysis

7.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Generative Artificial Intelligence (AI) In Drug Discovery Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Generative Artificial Intelligence (AI) In Drug Discovery Market Segmentation

9.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Molecule, Large Molecule

9.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

9.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

9.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

9.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

10. Generative Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis

10.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market

11.1. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Generative Artificial Intelligence (AI) In Drug Discovery Market

12.1. China Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Generative Artificial Intelligence (AI) In Drug Discovery Market

13.1. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market

14.1. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market

15.1. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market

16.1. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market

17.1. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Generative Artificial Intelligence (AI) In Drug Discovery Market

18.1. Taiwan Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Generative Artificial Intelligence (AI) In Drug Discovery Market

19.1. South East Asia Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

20.1. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Generative Artificial Intelligence (AI) In Drug Discovery Market

21.1. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market

22.1. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Generative Artificial Intelligence (AI) In Drug Discovery Market

23.1. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market

24.1. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market

25.1. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

26.1. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market

27.1. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Generative Artificial Intelligence (AI) In Drug Discovery Market

28.1. North America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Generative Artificial Intelligence (AI) In Drug Discovery Market

29.1. USA Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market

30.1. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Generative Artificial Intelligence (AI) In Drug Discovery Market

31.1. South America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market

32.1. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market

33.1. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market

34.1. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Generative Artificial Intelligence (AI) In Drug Discovery Market Regulatory and Investment Landscape

36. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles

36.1. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Generative Artificial Intelligence (AI) In Drug Discovery Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Generative Artificial Intelligence (AI) In Drug Discovery Market Company Profiles

36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. IBM Research Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Schrödinger Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Generative Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies

Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc.

38. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market

40. Generative Artificial Intelligence (AI) In Drug Discovery Market High Potential Countries, Segments and Strategies

40.1 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2030 - Countries Offering Most New Opportunities

40.2 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2030 - Segments Offering Most New Opportunities

40.3 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Overview Of Key Products - Product Examples
  • Table 2: Global Generative Artificial Intelligence (AI) In Drug Discovery Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Supply Chain Analysis
  • Table 4: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Raw Material Providers
  • Table 5: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Resource Providers
  • Table 6: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Manufacturers (Suppliers)
  • Table 7: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Distributors And Channel Partners
  • Table 8: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Key Technologies & Future Trends
  • Table 9: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Trends
  • Table 10: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major End Users
  • Table 11: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Generative Artificial Intelligence (AI) In Drug Discovery Market - TAM, US$ Billion, 2025
  • Table 15: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Generative Artificial Intelligence (AI) In Drug Discovery Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Generative Artificial Intelligence (AI) In Drug Discovery Market - Company Scoring Matrix
  • Table 96: Bayer AG Financial Performance
  • Table 97: NVIDIA Corporation Financial Performance
  • Table 98: Merck KGaA Financial Performance
  • Table 99: IBM Research Financial Performance
  • Table 100: Schrödinger Inc. Financial Performance
  • Table 101: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Competitive Dashboard
  • Table 103: Global Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 106: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Generative Artificial Intelligence (AI) In Drug Discovery Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Supply Chain Analysis
  • Figure 4: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Raw Material Providers
  • Figure 5: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Resource Providers
  • Figure 6: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Distributors And Channel Partners
  • Figure 8: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Key Technologies & Future Trends
  • Figure 9: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major Trends
  • Figure 10: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Major End Users
  • Figure 11: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Generative Artificial Intelligence (AI) In Drug Discovery Market - TAM, US$ Billion, 2025
  • Figure 15: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Generative Artificial Intelligence (AI) In Drug Discovery Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Generative Artificial Intelligence (AI) In Drug Discovery Market - Company Scoring Matrix
  • Figure 96: Bayer AG Financial Performance
  • Figure 97: NVIDIA Corporation Financial Performance
  • Figure 98: Merck KGaA Financial Performance
  • Figure 99: IBM Research Financial Performance
  • Figure 100: Schrödinger Inc. Financial Performance
  • Figure 101: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Competitive Dashboard
  • Figure 103: Global Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 106: Global, Generative Artificial Intelligence (AI) In Drug Discovery Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Frequently Asked Questions

The Generative Artificial Intelligence (AI) In Drug Discovery market was valued at $0.25 billion in 2025, increased to $0.33 billion in 2026, and is projected to reach $0.86 billion by 2030.

The global Generative Artificial Intelligence (AI) In Drug Discovery market is expected to grow at a CAGR of 27.0% from 2026 to 2035 to reach $0.86 billion by 2035.

Some Key Players in the Generative Artificial Intelligence (AI) In Drug Discovery market Include, Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharm

Major trend in this market includes: Advanced AI Solutions To Revolutionize Drug Discovery And Precision Medicine. For further insights on this market. request a sample here

North America was the largest region in the generative AI in drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI)

Customer representative image Book your 30 minutes free consultation with our research experts